Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-29, Stock:LLY, The news for the past five days is as follows:
2019-01-22: NEWS1: U.S. insulin costs per patient nearly doubled from 2012 to 2016 -study.NEWS2: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS3: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS4: Company News For Jan 22, 2019.NEWS5: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS6: Company News For Jan 22, 2019.NEWS7: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS8: U.S. insulin costs per patient nearly doubled from 2012 to 2016 -study.
2019-01-23: NEWS1: Noteworthy ETF Outflows: XLV, ABT, LLY, TMO.NEWS2: Noteworthy ETF Outflows: XLV, ABT, LLY, TMO.NEWS3: 5 Best Biotech Bets Likely to Outperform Estimates in Q4.NEWS4: How Many Insiders Bought Eli Lilly and Company (NYSE:LLY) Shares?.NEWS5: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS6: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS7: 6 Stocks to Prepare for a Global Economic Slowdown.NEWS8: Government Employees Affected by Federal Shutdown Encouraged to Contact Lilly Diabetes Solution Center to Access Insulin.
2019-01-24: NEWS1: Moderna's Hot New mRNA Technology Has Competition.NEWS2: Moderna's Hot New mRNA Technology Has Competition.NEWS3: What's Behind the Biotech ETF Rally to Start 2019?.NEWS4: What's Behind the Biotech ETF Rally to Start 2019?.NEWS5: Moderna&apos;s Hot New mRNA Technology Has Competition.NEWS6: Bristol-Myers (BMY) Beats Q4 Earnings, Withdraws Opdivo sBLA.NEWS7: Bristol-Myers (BMY) Beats Q4 Earnings, Withdraws Opdivo sBLA.NEWS8: What's Behind the Biotech ETF Rally to Start 2019?.NEWS9: Sanofi's (SNY) Influenza Vaccine Gets FDA Approval for Kids.NEWS10: Sanofi's (SNY) Influenza Vaccine Gets FDA Approval for Kids.NEWS11: The Zacks Analyst Blog Highlights: Archer Daniels Midland, Molina Healthcare, Eli Lilly, Spark Energy and Lamb Weston.NEWS12: The Zacks Analyst Blog Highlights: Archer Daniels Midland, Molina Healthcare, Eli Lilly, Spark Energy and Lamb Weston.NEWS13: Skyrocketing health care costs key topic at Davos.NEWS14: Bristol-Myers (BMY) Beats Q4 Earnings, Withdraws Opdivo sBLA.NEWS15: The Zacks Analyst Blog Highlights: Archer Daniels Midland, Molina Healthcare, Eli Lilly, Spark Energy and Lamb Weston.NEWS16: Sanofi's (SNY) Influenza Vaccine Gets FDA Approval for Kids.NEWS17: Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?.NEWS18: Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?.NEWS19: Does Johnson & Johnson&apos;s Grim Outlook Spell Trouble for Big Pharma Stocks?.
2019-01-25: NEWS1: Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen.NEWS2: Merck KGaA Gives Vertex Rights to Two Gene-Editing Compounds.NEWS3: Merck KGaA Gives Vertex Rights to Two Gene-Editing Compounds.NEWS4: Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV.NEWS5: Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV.NEWS6: Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV.NEWS7: Merck KGaA Gives Vertex Rights to Two Gene-Editing Compounds.
2019-01-28: NEWS1: Dr. Reddy's (RDY) to Report Q3 Earnings: What's in Store?.NEWS2: Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results.NEWS3: Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results.NEWS4: Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results.NEWS5: The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck.NEWS6: The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck.NEWS7: The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck.

Answer: Rise